Who invested in Phrontline Biopharma?
Phrontline Biopharma's investors include Samsung Venture Investment.

Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2025, from 1 source
Phrontline Biopharma's investors include Samsung Venture Investment.
Phrontline Biopharma has raised $60M across 1 round since 2025.
Phrontline Biopharma's most recent round was a Seed of $60M in Nov 2025.
Its most recent round, $60M in Nov 2025, is also its largest on record.
Phrontline Biopharma's first round on record, in Nov 2025, was backed by Samsung Venture Investment.
Phrontline Biopharma's latest named round is a Seed, in Nov 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.